Identification and characterization of novel ETV4 splice variants in prostate cancer

[1]  A. Scorilas,et al.  Structural characterization and expression analysis of novel MAPK1 transcript variants with the development of a multiplexed targeted nanopore sequencing approach. , 2022, The international journal of biochemistry & cell biology.

[2]  A. Scorilas,et al.  Nanopore Sequencing Unveils Diverse Transcript Variants of the Epithelial Cell-Specific Transcription Factor Elf-3 in Human Malignancies , 2021, Genes.

[3]  Y. Hayashizaki,et al.  Nanopore sequencing reveals TACC2 locus complexity and diversity of isoforms transcribed from an intronic promoter , 2021, Scientific Reports.

[4]  M. Ikawa,et al.  A novel tissue specific alternative splicing variant mitigates phenotypes in Ets2 frame-shift mutant models , 2021, Scientific Reports.

[5]  G. Nesi,et al.  ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21 , 2020, Journal of Hematology & Oncology.

[6]  T. Haferlach,et al.  Complex Landscape of Alternative Splicing in Myeloid Neoplasms , 2020, Leukemia.

[7]  Jiannis Ragoussis,et al.  Methodologies for Transcript Profiling Using Long-Read Technologies , 2020, Frontiers in Genetics.

[8]  J. Valcárcel,et al.  Roles and mechanisms of alternative splicing in cancer — implications for care , 2020, Nature Reviews Clinical Oncology.

[9]  Jun Luo,et al.  Alternative splicing in prostate cancer , 2018, Nature Reviews Clinical Oncology.

[10]  Olga Anczuków,et al.  Alternative‐splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics , 2018, Wiley interdisciplinary reviews. RNA.

[11]  C. Barbieri,et al.  Molecular Subtypes of Prostate Cancer , 2018, Current Oncology Reports.

[12]  L. McIntosh,et al.  ETV4 and AP1 transcription factors form multivalent interactions with three sites on the MED25 activator-interacting domain , 2017, bioRxiv.

[13]  Heng Li,et al.  Minimap2: pairwise alignment for nucleotide sequences , 2017, Bioinform..

[14]  Michael C. Ostrowski,et al.  The ETS family of oncogenic transcription factors in solid tumours , 2017, Nature Reviews Cancer.

[15]  L. McIntosh,et al.  Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5 , 2017, Nucleic acids research.

[16]  Kiyoshi Asai,et al.  Training alignment parameters for arbitrary sequencers with LAST-TRAIN , 2016, Bioinform..

[17]  C. Sette,et al.  Alternative splicing and cell survival: from tissue homeostasis to disease , 2016, Cell Death and Differentiation.

[18]  Eunhee Kim,et al.  RNA splicing factors as oncoproteins and tumour suppressors , 2016, Nature Reviews Cancer.

[19]  M. Swanson,et al.  RNA mis-splicing in disease , 2015, Nature Reviews Genetics.

[20]  Wen J. Li,et al.  Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation , 2015, Nucleic Acids Res..

[21]  J. Oxley,et al.  Quantitative analysis of ERG expression and its splice isoforms in formalin-fixed, paraffin-embedded prostate cancer samples: association with seminal vesicle invasion and biochemical recurrence. , 2014, American journal of clinical pathology.

[22]  S. Srivastava,et al.  Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer , 2014, Genes & cancer.

[23]  R. Cardiff,et al.  ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer , 2013, Proceedings of the National Academy of Sciences.

[24]  L. Cartegni,et al.  5′ UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer , 2013, PloS one.

[25]  R. Notaro,et al.  Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition , 2012, Oncogenesis.

[26]  N. Wernert,et al.  Novel identification of the ETS-1 splice variants p42 and p27 in prostate cancer cell lines. , 2012, Oncology reports.

[27]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[28]  Auinash Kalsotra,et al.  Functional consequences of developmentally regulated alternative splicing , 2011, Nature Reviews Genetics.

[29]  Arul M Chinnaiyan,et al.  Common gene rearrangements in prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Peter C. Hollenhorst,et al.  Genomic and biochemical insights into the specificity of ETS transcription factors. , 2011, Annual review of biochemistry.

[31]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[32]  M. Frith,et al.  Adaptive seeds tame genomic sequence comparison. , 2011, Genome research.

[33]  Peter C. Hollenhorst,et al.  The ETS gene ETV4 is required for anchorage-independent growth and a cell proliferation gene expression program in PC3 prostate cells. , 2010, Genes & cancer.

[34]  Andrew R. Gehrke,et al.  Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo , 2010, The EMBO journal.

[35]  L. Young,et al.  Pea3 Transcription Factors and Wnt1-Induced Mouse Mammary Neoplasia , 2010, PloS one.

[36]  T. Nilsen,et al.  Expansion of the eukaryotic proteome by alternative splicing , 2010, Nature.

[37]  S. Arber,et al.  Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis , 2009, Nature Genetics.

[38]  David J. Elliott,et al.  Alternative splicing and biological heterogeneity in prostate cancer , 2009, Nature Reviews Urology.

[39]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[40]  D. Larsimont,et al.  Ets-1 p27: a novel Ets-1 isoform with dominant-negative effects on the transcriptional properties and the subcellular localization of Ets-1 p51 , 2009, Oncogene.

[41]  C. Tabin,et al.  Fgf-dependent Etv4/5 activity is required for posterior restriction of Sonic Hedgehog and promoting outgrowth of the vertebrate limb. , 2009, Developmental cell.

[42]  S. Dhanasekaran,et al.  A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. , 2008, Cancer research.

[43]  D. Tindall,et al.  Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. , 2008, Cancer research.

[44]  G. Jenster,et al.  Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer. , 2008, Cancer research.

[45]  J. Cuzick,et al.  Complex patterns of ETS gene alteration arise during cancer development in the human prostate , 2008, Oncogene.

[46]  Si Zhang,et al.  E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription. , 2007, Biochemical and biophysical research communications.

[47]  M. Rubin,et al.  TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion , 2006, The American journal of surgical pathology.

[48]  J. Tchinda,et al.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.

[49]  Arul M Chinnaiyan,et al.  TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. , 2006, Cancer research.

[50]  S. Ishida,et al.  Genomic structure and promoter activity of the E1AF gene, a member of the ETS oncogene family. , 2006, Biochemical and biophysical research communications.

[51]  J. Tchinda,et al.  Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer , 2005, Science.

[52]  J. Pelletier,et al.  Activation of the WT1 tumor suppressor gene promoter by Pea3 , 2004, FEBS letters.

[53]  I. Kola,et al.  Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16. , 2004, Gene.

[54]  B. Hogan,et al.  Role for ETS domain transcription factors Pea3/Erm in mouse lung development. , 2003, Developmental biology.

[55]  Y. De Launoit,et al.  PEA3 transcription factors are expressed in tissues undergoing branching morphogenesis and promote formation of duct-like structures by mammary epithelial cells in vitro. , 2003, Developmental biology.

[56]  L. R. Howe,et al.  Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. , 2003, Cancer research.

[57]  B. Davidson,et al.  PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[58]  Vincenzo De Paola,et al.  ETS Gene Pea3 Controls the Central Position and Terminal Arborization of Specific Motor Neuron Pools , 2002, Neuron.

[59]  Bosiljka Tasic,et al.  Alternative pre-mRNA splicing and proteome expansion in metazoans , 2002, Nature.

[60]  A. Sharrocks.  The ETS-domain transcription factor family , 2001, Nature Reviews Molecular Cell Biology.

[61]  M. Nishimura,et al.  Expression of E1AF/PEA3, an Ets‐related transcription factor in human non‐small‐cell lung cancers: Its relevance in cell motility and invasion , 2001, International journal of cancer.

[62]  A. Sharrocks,et al.  DNA Binding by the ETS-domain Transcription Factor PEA3 Is Regulated by Intramolecular and Intermolecular Protein·Protein Interactions* , 2001, The Journal of Biological Chemistry.

[63]  J. Hassell,et al.  The PEA3 Ets Transcription Factor Comprises Multiple Domains That Regulate Transactivation and DNA Binding* , 2001, The Journal of Biological Chemistry.

[64]  M. Hung,et al.  The Ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis , 2000, Nature Medicine.

[65]  M. Vidaud,et al.  Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human , 1999, Oncogene.

[66]  A. Givan,et al.  Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid , 1999, Clinical & Experimental Metastasis.

[67]  D. Monté,et al.  The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA. , 1996, Oncogene.

[68]  P. Defossez,et al.  Two functionally distinct domains responsible for transactivation by the Ets family member ERM. , 1996, Oncogene.

[69]  F. Higashino,et al.  A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. , 1996, Oncogene.

[70]  M. Klemsz,et al.  The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. , 1990, Genes & development.

[71]  N. Bhat,et al.  Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. , 1990, Oncogene.

[72]  Peter C. Hollenhorst,et al.  Oncogenic ETS Factors in Prostate Cancer. , 2019, Advances in experimental medicine and biology.

[73]  David P Turner,et al.  Understanding the role of ETS-mediated gene regulation in complex biological processes. , 2013, Advances in cancer research.

[74]  Y. De Launoit,et al.  The PEA3 group of ETS-related transcription factors. Role in breast cancer metastasis. , 2000, Advances in experimental medicine and biology.